ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
What is VIP (2mg) / BPC-157 (500mcg) x 30 Tablets?
What is VIP / BPC‑157 Tablets?
The VIP / BPC‑157 tablet formulation combines:
- Vasoactive Intestinal Peptide (VIP): A 28-amino-acid neuropeptide from the glucagon/secretin family. VIP activates VPAC1 and VPAC2 receptors, widely used in research on neuroendocrine regulation, smooth muscle function, vasodilation, and anti-inflammatory pathways.
- BPC‑157: A synthetic 15-amino-acid peptide derived from human gastric juice. BPC‑157 is used in preclinical studies for its wound healing, tissue regeneration, gastrointestinal protection, and cytoprotective effects.
This dual-tablet product enables investigations into both neuroendocrine signaling and combined regenerative mechanisms.
Chemical Structure of VIP / BPC‑157 Tablets
- VIP: 28 amino acids, sequence H‑His‑Ser‑Ile–...–Gly‑Lys‑Tyr‑Leu‑Leu, molecular weight ≈ 2,674 Da. It adopts an α‑helical structure during membrane interaction, essential for receptor binding.
- BPC‑157: Sequence Gly–Glu–Pro–Pro–Pro–Gly–Lys–Pro–Ala–Asp–Asp–Ala–Gly–Leu–Val, molecular formula C₆₂H₉₈N₁₆O₂₂, molecular weight ≈ 1,419.5 Da.
What Are the Effects of VIP / BPC‑157 Tablets?
- VIP – Vasodilation & Smooth Muscle Modulation: VIP functions as a potent vasodilator and bronchodilator. It regulates GI motility and secretions, and suppresses pro-inflammatory mediators in preclinical models.
- BPC‑157 – Cytoprotection & Healing: BPC‑157 promotes angiogenesis (via VEGFR‑2), supports mitochondrial and endothelial protection, and accelerates tissue healing in various models.
- Synergistic Investigative Potential: Researchers can explore combined effects on tissue perfusion, immune modulation, gut integrity, and neuromuscular recovery by testing both peptides together or separately in experimental systems.
Citations
- Bachem Knowledge Base – Vasoactive Intestinal Peptide (VIP): Overview of VIP BPC 157
- La Rosa S. “Vasoactive Intestinal Peptide (VIP).” Encyclopedia of Pathology. Springer; 2022. Overview of VIP BPC 157
- HandWiki – Chemistry: BPC‑157 sequence and formula (PubChem CID 9941957). Overview of VIP BPC 157
- DrugBank / NCATS Inxight Drugs – BPC‑157: Overview of VIP BPC 157
- Delgado M, et al. “VIP inhibits inflammatory responses in vivo.” J Immunol. 2004;173:5658–5668. PMID: 15494517. Overview of VIP BPC 157
- Williams JA. “Vasoactive intestinal polypeptide effects: vasodilation, bronchodilation, smooth-muscle relaxation.” Pancreapedia. 2020. Overview of VIP BPC 157
COA
Certificate of Analysis
HPLC
High Performance Liquid Chromatography
Product Quality Guarantee
HPLC TEST FEE
$100
PLUS Total amount of the Order + Shipping Fee
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
- Choosing a selection results in a full page refresh.
- Opens in a new window.